NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹582 Cr | ₹636 Cr | ₹754 Cr | ₹860 Cr | ₹903 Cr |
What is the latest Total Debt ratio of NECTAR LIFESCIENCES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹582 Cr |
| Mar2024 | ₹636 Cr |
| Mar2023 | ₹754 Cr |
| Mar2022 | ₹860 Cr |
| Mar2021 | ₹903 Cr |
How is Total Debt of NECTAR LIFESCIENCES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹582 Cr | -8.42 | |
| Mar2024 | ₹636 Cr | -15.69 | |
| Mar2023 | ₹754 Cr | -12.34 | |
| Mar2022 | ₹860 Cr | -4.81 | |
| Mar2021 | ₹903 Cr | - | |
Compare Total Debt of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹351.3 Cr | -13.3% | -22.3% | -54.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3% | -3.6% | -4.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.1% | 0.1% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -3.7% | 4% | 18.8% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.3% | -4.6% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -4.2% | -7% | -11.4% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -13.3% |
-22.3% |
-54.3% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses